Posted on

Multiple Sclerosis Awareness Month highlights need for better diagnosis research and available treatments

The current multiple sclerosis (MS) pipeline is strong and diverse with a total of 49 products in all stages and phases of clinical development. However, despite this increasing arsenal, diagnosing the disease still remains a challenge – even for experienced neurologists, says GlobalData, a leading data and analytics company.

Tissue biopsy is …

Read More